Label

How We Work

Grant

Back

Print

CureVac AG


November 2016
to test several messenger RNA vaccine candidates for picornaviruses with the goal to identify a safe and stable next generation vaccine for diseases with a disproportionate negative impact on smallholder farmers and their families
$898,637
62
Agricultural Development
Global Growth and Opportunity
Tübingen
http://www.curevac.com/

Visit Our Blog